These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 19327406)

  • 1. Matrix metalloproteinase 12 silencing: a therapeutic approach to treat pathological lung tissue remodeling?
    Garbacki N; Di Valentin E; Piette J; Cataldo D; Crahay C; Colige A
    Pulm Pharmacol Ther; 2009 Aug; 22(4):267-78. PubMed ID: 19327406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophage metalloelastase (MMP-12) as a target for inflammatory respiratory diseases.
    Lagente V; Le Quement C; Boichot E
    Expert Opin Ther Targets; 2009 Mar; 13(3):287-95. PubMed ID: 19236151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix metalloproteinase-9 in lung remodeling.
    Atkinson JJ; Senior RM
    Am J Respir Cell Mol Biol; 2003 Jan; 28(1):12-24. PubMed ID: 12495928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A therapeutic role for matrix metalloproteinase inhibitors in lung diseases?
    Vandenbroucke RE; Dejonckheere E; Libert C
    Eur Respir J; 2011 Nov; 38(5):1200-14. PubMed ID: 21659416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix metalloproteinase-12 (MMP-12) SNP affects MMP activity, lung macrophage infiltration and protects against emphysema in COPD.
    Haq I; Lowrey GE; Kalsheker N; Johnson SR
    Thorax; 2011 Nov; 66(11):970-6. PubMed ID: 21730350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metalloproteinase and inhibitor expression profiling of resorbing cartilage reveals pro-collagenase activation as a critical step for collagenolysis.
    Milner JM; Rowan AD; Cawston TE; Young DA
    Arthritis Res Ther; 2006; 8(5):R142. PubMed ID: 16919164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monocyte-derived dendritic cell subpopulations use different types of matrix metalloproteinases inhibited by GM6001.
    Kis-Toth K; Bacskai I; Gogolak P; Mazlo A; Szatmari I; Rajnavolgyi E
    Immunobiology; 2013 Nov; 218(11):1361-9. PubMed ID: 23870824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Status of research on matrix metalloproteinases (MMPs) in India.
    Bulbule A; Saraswati S; Kundu GC
    Expert Opin Ther Targets; 2011 Jun; 15(6):671-5. PubMed ID: 21476880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenic role of matrix metalloproteases and their inhibitors in asthma and chronic obstructive pulmonary disease and therapeutic relevance of matrix metalloproteases inhibitors.
    Cataldo DD; Gueders MM; Rocks N; Sounni NE; Evrard B; Bartsch P; Louis R; Noel A; Foidart JM
    Cell Mol Biol (Noisy-le-grand); 2003 Sep; 49(6):875-84. PubMed ID: 14656045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence or inhibition of matrix metalloproteinase-8 decreases ventilator-induced lung injury.
    Albaiceta GM; Gutierrez-Fernández A; García-Prieto E; Puente XS; Parra D; Astudillo A; Campestre C; Cabrera S; Gonzalez-Lopez A; Fueyo A; Taboada F; López-Otin C
    Am J Respir Cell Mol Biol; 2010 Nov; 43(5):555-63. PubMed ID: 19995943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelin-1-mediated signaling in the expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in astrocytes.
    He S; Prasanna G; Yorio T
    Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3737-45. PubMed ID: 17652746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of matrix metalloproteinases (MMPs) in the pathophysiology of chronic obstructive pulmonary disease (COPD): a therapeutic role for inhibitors of MMPs?
    Belvisi MG; Bottomley KM
    Inflamm Res; 2003 Mar; 52(3):95-100. PubMed ID: 12755372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix metalloproteinase-2 (MMP-2) and MMP-9 in pulmonary pathology.
    Chakrabarti S; Patel KD
    Exp Lung Res; 2005; 31(6):599-621. PubMed ID: 16019990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The role of matrix metalloproteinases in extracellular matrix remodelling in chronic obstructive pulmonary disease rat models].
    Li H; Cui D; Tong X; Ma N; Gao Y; Cui X; Lu L; Wang D; Liang Y
    Zhonghua Nei Ke Za Zhi; 2002 Jun; 41(6):393-8. PubMed ID: 12137602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Latanoprost induces matrix metalloproteinase-1 expression in human nonpigmented ciliary epithelial cells through a cyclooxygenase-2-dependent mechanism.
    Hinz B; Rösch S; Ramer R; Tamm ER; Brune K
    FASEB J; 2005 Nov; 19(13):1929-31. PubMed ID: 16076963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in the respiratory tract: potential implications in asthma and other lung diseases.
    Gueders MM; Foidart JM; Noel A; Cataldo DD
    Eur J Pharmacol; 2006 Mar; 533(1-3):133-44. PubMed ID: 16487964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of potent and selective matrix metalloprotease 12 inhibitors for the potential treatment of chronic obstructive pulmonary disease (COPD).
    Wu Y; Li J; Wu J; Morgan P; Xu X; Rancati F; Vallese S; Raveglia L; Hotchandani R; Fuller N; Bard J; Cunningham K; Fish S; Krykbaev R; Tam S; Goldman SJ; Williams C; Mansour TS; Saiah E; Sypek J; Li W
    Bioorg Med Chem Lett; 2012 Jan; 22(1):138-43. PubMed ID: 22153340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increase in macrophage elastase (MMP-12) in lungs from patients with chronic obstructive pulmonary disease.
    Molet S; Belleguic C; Lena H; Germain N; Bertrand CP; Shapiro SD; Planquois JM; Delaval P; Lagente V
    Inflamm Res; 2005 Jan; 54(1):31-6. PubMed ID: 15723202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic inhibition of matrix metalloproteinases for the treatment of chronic obstructive pulmonary disease (COPD).
    Daheshia M
    Curr Med Res Opin; 2005 Apr; 21(4):587-94. PubMed ID: 15899108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of matrix metalloproteinase-9 gene expression in MPP+- or 6-OHDA-treated human neuroblastoma SK-N-BE(2)C cells.
    Kim SY; Woo MS; Park JS; Kim HS
    Neurochem Int; 2010 Feb; 56(3):437-42. PubMed ID: 19962414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.